Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
APstem Therapeutics, Inc. Logo
APstem Therapeutics, Inc. Growth Score
28
CB Rank
68457
Heat Score
64
NOVEL STEM CELL TECHNOLOGY TARGETING UNMET MEDICAL NEEDS
Founded
obfuscation
PrivateSeed Fremont, California, United States1-10 www.apstemtx.com/
Biotechnology
Health Care
Life Science
Overview

APstem Therapeutics, Inc.
Total Funding
obfuscation
Growth Score
28
Heat Score
64

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score28
-2 pts
in past quarter
Heat Score 64
-10 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About APstem Therapeutics, Inc.

CB Rank
68457
NOVEL STEM CELL TECHNOLOGY TARGETING UNMET MEDICAL NEEDS
Founded
obfuscation
PrivateSeed Fremont, California, United States1-10 www.apstemtx.com/
Biotechnology
Health Care
Life Science

Funding Rounds

Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

  • Photo of Min Hu
    Min Hu: Founder and CEO
  • Photo of Shaowei Li
    Shaowei Li: Co-Founder and CSO
    Past Role: Stanford University School of Medicine, Research Assistant

Details

Legal Name APstem Therapeutics, Inc.
Operating Status Active
Company Type For Profit
Founders  Bowen Liu, Min Hu, Shaowei Li
About the Company
With APstem Therapeutics’ breakthrough discovery of Adult Pluripotent Stem Cells (APSCs™), we are on a mission to eradicate difficult-to-heal diseases and conquer the challenges of aging.
Phone Number 510-573-0910
Contact Email info@apstemtx.com
Diversity Spotlight 
Women Founded
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Adult High-Plasticity Stem Cells (AHPSCs™)
A unique class of stem cells isolated from adult peripheral blood, capable of differentiating into various cell types for tissue repair and regeneration.
AP-Skin-01
An allogeneic stem cell product derived from AHPSCs™ designed to treat diabetic ulcers by promoting full skin structural reconstruction, angiogenesis, and reducing inflammation.

Research & Development

APstem Therapeutics, Inc. is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - APstem Therapeutics, Inc. Logo
Seed Round - APstem Therapeutics, Inc.
3
obfuscation
— Seed
obfuscation
Seed Round - APstem Therapeutics, Inc. Logo
Seed Round - APstem Therapeutics, Inc.
3
obfuscation
— Seed
obfuscation
Seed Round - APstem Therapeutics, Inc. Logo
Seed Round - APstem Therapeutics, Inc.
3
obfuscation
— Seed
obfuscation
Seed Round - APstem Therapeutics, Inc. Logo
Seed Round - APstem Therapeutics, Inc.
3
obfuscation
— Seed
obfuscation
Seed Round - APstem Therapeutics, Inc. Logo
Seed Round - APstem Therapeutics, Inc.
3
obfuscation
— Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - APstem Therapeutics, Inc. Logo
Seed Round - APstem Therapeutics, Inc.
3
obfuscation
— Seed
obfuscation
Seed Round - APstem Therapeutics, Inc. Logo
Seed Round - APstem Therapeutics, Inc.
3
obfuscation
— Seed
obfuscation
Seed Round - APstem Therapeutics, Inc. Logo
Seed Round - APstem Therapeutics, Inc.
3
obfuscation
— Seed
obfuscation
Seed Round - APstem Therapeutics, Inc. Logo
Seed Round - APstem Therapeutics, Inc.
3
obfuscation
— Seed
obfuscation
Seed Round - APstem Therapeutics, Inc. Logo
Seed Round - APstem Therapeutics, Inc.
3
obfuscation
— Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Beyond Ventures Logo
Beyond Ventures
—
Seed Round - APstem Therapeutics, Inc. Logo
Seed Round - APstem Therapeutics, Inc.
—
Beyond Ventures Logo
Beyond Ventures
—
Seed Round - APstem Therapeutics, Inc. Logo
Seed Round - APstem Therapeutics, Inc.
—
Beyond Ventures Logo
Beyond Ventures
—
Seed Round - APstem Therapeutics, Inc. Logo
Seed Round - APstem Therapeutics, Inc.
—
Beyond Ventures Logo
Beyond Ventures
—
Seed Round - APstem Therapeutics, Inc. Logo
Seed Round - APstem Therapeutics, Inc.
—
Beyond Ventures Logo
Beyond Ventures
—
Seed Round - APstem Therapeutics, Inc. Logo
Seed Round - APstem Therapeutics, Inc.
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Contacts 6

Employee Profiles

News

News and Press

News•Nov 6, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 25, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

45
43.18%
 in past month

IT Spend

$65.2KThis year, APstem Therapeutics, Inc. is projected to spend $65.2K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Corporate Transparency Act (CTA) Logo
Corporate Transparency Act (CTA)
73
Facebook (FB) Logo
Facebook (FB)
72
Meta Platforms, Inc. Logo
Meta Platforms, Inc.
72

Active Website Tech Count

2APstem Therapeutics, Inc. is actively using 2 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m.

Total IP

3The intellectual property of APstem Therapeutics, Inc. includes 3 registered patents primarily in the 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is APstem Therapeutics, Inc.'s headquarters? APstem Therapeutics, Inc. is located in Fremont, California, United States.Who invested in APstem Therapeutics, Inc.? APstem Therapeutics, Inc. has 5 investors including Beyond Ventures and  Magic Capital.When was the last funding round for APstem Therapeutics, Inc.? APstem Therapeutics, Inc. closed its last funding round on
obfuscation
from a Seed round.Who are APstem Therapeutics, Inc.'s competitors? Alternatives and possible competitors to APstem Therapeutics, Inc. may include Integra LifeSciences, MiMedx Group, and  Mesoblast.How much funding has APstem Therapeutics, Inc. raised to date? APstem Therapeutics, Inc. has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|